Ignite Creation Date:
2024-07-17 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06463171
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-06-10
Brief Title:
Phase II Trial of Almonertinib Plus Lastet for EGFR Non-small Cell Lung Cancer
Sponsor:
Shanghai Pulmonary Hospital Shanghai China
Organization:
Shanghai Pulmonary Hospital Shanghai China
Organization Data
Organization:
Shanghai Pulmonary Hospital Shanghai China
Class:
OTHER
Study ID:
2024LY0323
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Pulmonary Hospital Shanghai China
Lead Sponsor Class:
OTHER
Responsible Party:
Chunxia Su
Responsible Party Title:
Director of the Clinical Research Center
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai Pulmonary Hospital Shanghai China
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Shanghai Zhongshan Hospital | OTHER |
| The First Affiliated Hospital of Xiamen University | OTHER |